Interesting to see the massive jump, but you're right its...

First 79 Last

tim8wilson

534 Posts.

28/02/18

12:48

Post #: 31413157

Originally posted by macherry ↑

Hi, just done some quick analysis on both companies. I really can't understand the current increase in the SGH share price following their results announcement, at least compared to SHJ. SHJ has lower revenue but seems to be operating more efficiently, has lower debt, more WIP, is PROFITABLE, paid a DIVIDEND, and yet still has a lower market cap? Someone must think SGH is going to significantly turn the operational performance around.

Column 1 Column 2 Column 3

1 31-Dec-17

2 SHJ SGH

3 $'000 $'000

4

5 Revenue 88,231 96,295

6 Employee expenses 45,336 60,982

7 Revenue per dollar of employee costs 1.95 1.58

8

9 EBITDA 16,477 (8,662)

10 EBITDA Margin 19% (9%)

11

12 NPAT 7,826 (21,191)

13

14 Operating cash flow 4,879 (798)

15

16 EPS (cps) 4.52 (3.16)

17 Dividend (cps) 1.00 -

18

19 Working capital balances:

20 Receivables and unbilled disbursements 92,432 85,264

21 WIP 247,610 237,140

22 Trade creditors (67,730) (57,092)

23

24 Debt (Borrowings) (72,359) (117,138)

25

26 Share price 0.68 2.30

27 Shares outstanding 173,161,812 69,527,235

28 Market capitalisation 117,750,032 159,912,641

Expand

Interesting to see the massive jump, but you're right its because people aren't comparing the companies on a like for like basis. Slater is also about to downsize (Employee expenses will reduce but there will be massive one off restructure costs) while Shine is slowly growing. A 20% jump in price for Slater makes no sense.

SHJ Price at posting: 69.0¢ Sentiment: Hold Disclosure: Held

Upvote

0 Great analysis

Top Stories

NWH

"A punch in the face": HotCopper users unhappy with NOVONIX's 60cps raise

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 169 more messages in this thread...

First 79 Last

Add SHJ (ASX) to my watchlist

(20min delay)
Last 89.5¢		Change 0.000(0.00%)		Mkt cap ! $144.2M

Open	High	Low	Value	Volume
89.5¢	89.5¢	89.5¢	$1	1

Buyers (Bids)

No.	Vol.	Price($)
1	10000	85.5¢

Sellers (Offers)

Price($)	Vol.	No.
89.0¢	250329	2

View Market Depth

No.	Vol.	Price($)
1	28	0.840
3	5177	0.825
1	1	0.820
1	7723	0.800
1	936	0.750

Price($)	Vol.	No.
0.850	56508	9
0.865	1155	1
0.890	14633	1
0.900	10402	3
0.940	30000	1

Last trade - 10.09am 26/11/2024 (20 minute delay)

SHJ (ASX) Chart

	Column 1	Column 2	Column 3
1		31-Dec-17
2		SHJ	SGH
3		$'000	$'000
4
5	Revenue	88,231	96,295
6	Employee expenses	45,336	60,982
7	Revenue per dollar of employee costs	1.95	1.58
8
9	EBITDA	16,477	(8,662)
10	EBITDA Margin	19%	(9%)
11
12	NPAT	7,826	(21,191)
13
14	Operating cash flow	4,879	(798)
15
16	EPS (cps)	4.52	(3.16)
17	Dividend (cps)	1.00	-
18
19	Working capital balances:
20	Receivables and unbilled disbursements	92,432	85,264
21	WIP	247,610	237,140
22	Trade creditors	(67,730)	(57,092)
23
24	Debt (Borrowings)	(72,359)	(117,138)
25
26	Share price	0.68	2.30
27	Shares outstanding	173,161,812	69,527,235
28	Market capitalisation	117,750,032	159,912,641

Interesting to see the massive jump, but you're right its...

Top Stories

"A punch in the face": HotCopper users unhappy with NOVONIX's 60cps raise

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Buyers (Bids)

Sellers (Offers)